Cargando…
Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
Excessive secretion of triglyceride-rich very low-density lipoproteins (VLDL-TG) contributes to diabetic dyslipidemia. Earlier studies have indicated a possible role for the hypothalamus and autonomic nervous system in the regulation of VLDL-TG. In the current study, we investigated whether the auto...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331766/ https://www.ncbi.nlm.nih.gov/pubmed/22461566 http://dx.doi.org/10.2337/db11-1142 |
_version_ | 1782230140357443584 |
---|---|
author | Bruinstroop, Eveline Pei, Lei Ackermans, Mariëtte T. Foppen, Ewout Borgers, Anke J. Kwakkel, Joan Alkemade, Anneke Fliers, Eric Kalsbeek, Andries |
author_facet | Bruinstroop, Eveline Pei, Lei Ackermans, Mariëtte T. Foppen, Ewout Borgers, Anke J. Kwakkel, Joan Alkemade, Anneke Fliers, Eric Kalsbeek, Andries |
author_sort | Bruinstroop, Eveline |
collection | PubMed |
description | Excessive secretion of triglyceride-rich very low-density lipoproteins (VLDL-TG) contributes to diabetic dyslipidemia. Earlier studies have indicated a possible role for the hypothalamus and autonomic nervous system in the regulation of VLDL-TG. In the current study, we investigated whether the autonomic nervous system and hypothalamic neuropeptide Y (NPY) release during fasting regulates hepatic VLDL-TG secretion. We report that, in fasted rats, an intact hypothalamic arcuate nucleus and hepatic sympathetic innervation are necessary to maintain VLDL-TG secretion. Furthermore, the hepatic sympathetic innervation is necessary to mediate the stimulatory effect of intracerebroventricular administration of NPY on VLDL-TG secretion. Since the intracerebroventricular administration of NPY increases VLDL-TG secretion by the liver without affecting lipolysis, its effect on lipid metabolism appears to be selective to the liver. Together, our findings indicate that the increased release of NPY during fasting stimulates the sympathetic nervous system to maintain VLDL-TG secretion at a postprandial level. |
format | Online Article Text |
id | pubmed-3331766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-33317662013-05-01 Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System Bruinstroop, Eveline Pei, Lei Ackermans, Mariëtte T. Foppen, Ewout Borgers, Anke J. Kwakkel, Joan Alkemade, Anneke Fliers, Eric Kalsbeek, Andries Diabetes Metabolism Excessive secretion of triglyceride-rich very low-density lipoproteins (VLDL-TG) contributes to diabetic dyslipidemia. Earlier studies have indicated a possible role for the hypothalamus and autonomic nervous system in the regulation of VLDL-TG. In the current study, we investigated whether the autonomic nervous system and hypothalamic neuropeptide Y (NPY) release during fasting regulates hepatic VLDL-TG secretion. We report that, in fasted rats, an intact hypothalamic arcuate nucleus and hepatic sympathetic innervation are necessary to maintain VLDL-TG secretion. Furthermore, the hepatic sympathetic innervation is necessary to mediate the stimulatory effect of intracerebroventricular administration of NPY on VLDL-TG secretion. Since the intracerebroventricular administration of NPY increases VLDL-TG secretion by the liver without affecting lipolysis, its effect on lipid metabolism appears to be selective to the liver. Together, our findings indicate that the increased release of NPY during fasting stimulates the sympathetic nervous system to maintain VLDL-TG secretion at a postprandial level. American Diabetes Association 2012-05 2012-04-13 /pmc/articles/PMC3331766/ /pubmed/22461566 http://dx.doi.org/10.2337/db11-1142 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Metabolism Bruinstroop, Eveline Pei, Lei Ackermans, Mariëtte T. Foppen, Ewout Borgers, Anke J. Kwakkel, Joan Alkemade, Anneke Fliers, Eric Kalsbeek, Andries Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System |
title | Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System |
title_full | Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System |
title_fullStr | Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System |
title_full_unstemmed | Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System |
title_short | Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System |
title_sort | hypothalamic neuropeptide y (npy) controls hepatic vldl-triglyceride secretion in rats via the sympathetic nervous system |
topic | Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331766/ https://www.ncbi.nlm.nih.gov/pubmed/22461566 http://dx.doi.org/10.2337/db11-1142 |
work_keys_str_mv | AT bruinstroopeveline hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT peilei hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT ackermansmariettet hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT foppenewout hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT borgersankej hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT kwakkeljoan hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT alkemadeanneke hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT flierseric hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem AT kalsbeekandries hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem |